Atrial Fibrillation Surgery Market Share

North American Market Forecast

The market share of atrial fibrillation surgery in North America, amongst the market in all the other regions, is projected to be the largest with a share of about 32% by the end of 2037. The market's growth can be attributed majorly to the increasing technological advancements in the region's atrial fibrillation surgery field. Further, the growing prevalence of cardiac conditions in the aging population is another factor that is anticipated to boost market growth. For instance, out of 18.2 million adults, 6.7 % of the adult population is affected by coronary heart disease. It is also estimated that 51% of heart procedures are performed on adults who are 65 and above years of age. The availability of more favorable insurance coverage is also estimated to contribute to the growth of the market in the United States, given its presence of key players. The US Food and Drug Administration granted Boston Scientific Corporation approval of the WATCHMAN FLXLARGE Left Atrial Appendage Closure LAAC device, in July 2020, indicated to reduce the risk of stroke in patients with non-valvular atrial fibrillation (NVAF).

APAC Market Statistics

The Asia Pacific atrial fibrillation surgery market is estimated to be the second largest, registering a significant share by the end of 2037. The growth of the market can be attributed majorly to the increasing popularity of the use of minimum-invasive procedures in the region. Moreover, demand for the market is increasing due to rising healthcare costs. Furthermore, the technical advances in atrial fibrillation surgery have been considerable and this has raised the cure rate of patients. Growing obesity and heart disease rates across the region are also driving the atrial fibrillation industry. Additionally, heart disease is one of the leading causes of death worldwide. The number of people suffering from it is increasing exponentially due to a change in lifestyle. For these reasons, it is expected that the market for minimally invasive procedures increases as a result of advantages including reduced patient discomfort, injury, hospital stays, and faster recovery.

Europe Market Forecast

Further, the market in Europe, amongst the market in all the other regions, is projected to hold a majority of the share by the end of 2037. The growth of the market can be attributed majorly to the increasing prevalence of atrial fibrillation conditions and a rise in general awareness of the same. Moreover, the increased healthcare expenditure and growing disposable income are estimated to contribute to the growth of the market in the forecast period.